| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4241435 | Journal of Vascular and Interventional Radiology | 2008 | 8 Pages |
Abstract
There was a significantly greater degree of tumor infarction in patients treated with tris-acryl gelatin microspheres during UAE than in patients who received PVA microspheres administered in accordance with a newly refined protocol. Given the known risk of recurrence in patients with persistent tumor enhancement after UAE, it is concluded that tris-acryl gelatin microspheres should be the preferred agent for UAE at this time.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Gary P. MD, Avi MD, Michael MD, Kenneth MD, Meridith MD, Allen MD,